603367 辰欣药业
午间休市 03-11 11:29:49
资讯
新帖
简况
辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%
证券之星 · 01-08
辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%
1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股
证券之星 · 01-05
1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股
11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元
证券之星 · 2025-11-24
11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元
每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动
证券之星 · 2025-11-23
每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动
11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股
证券之星 · 2025-11-20
11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股
辰欣药业（603367）披露持股5%以上股东一致行动人更名及经营范围变更，11月17日股价下跌1.53%
证券之星 · 2025-11-17
辰欣药业（603367）披露持股5%以上股东一致行动人更名及经营范围变更，11月17日股价下跌1.53%
每周股票复盘：辰欣药业（603367）股东户数下降14.38%，三季度净利增19.61%
证券之星 · 2025-11-02
每周股票复盘：辰欣药业（603367）股东户数下降14.38%，三季度净利增19.61%
股市必读：辰欣药业（603367）10月30日收盘跌5.6%，主力净流出1.25亿元
证券之星 · 2025-10-31
股市必读：辰欣药业（603367）10月30日收盘跌5.6%，主力净流出1.25亿元
辰欣药业(603367.SH)发布前三季度业绩，归母净利润3.82亿元，同比下降4.05%
智通财经 · 2025-10-28
辰欣药业(603367.SH)发布前三季度业绩，归母净利润3.82亿元，同比下降4.05%
异动快报：辰欣药业（603367）10月22日10点46分触及涨停板
证券之星 · 2025-10-22
异动快报：辰欣药业（603367）10月22日10点46分触及涨停板
每周股票复盘：辰欣药业（603367）因股价涨幅偏离上榜龙虎榜
证券之星 · 2025-10-19
每周股票复盘：辰欣药业（603367）因股价涨幅偏离上榜龙虎榜
10月17日辰欣药业（603367）龙虎榜数据：游资上海超短帮上榜
证券之星 · 2025-10-17
10月17日辰欣药业（603367）龙虎榜数据：游资上海超短帮上榜
每周股票复盘：辰欣药业（603367）股东减持452万股，拟派现8511万
证券之星 · 2025-09-28
每周股票复盘：辰欣药业（603367）股东减持452万股，拟派现8511万
股市必读：9月24日辰欣药业发布公告，股东减持352万股
证券之星 · 2025-09-25
股市必读：9月24日辰欣药业发布公告，股东减持352万股
9月23日辰欣药业发布公告，股东减持100万股
证券之星 · 2025-09-23
9月23日辰欣药业发布公告，股东减持100万股
每周股票复盘：辰欣药业（603367）股东大会审议通过取消监事会
证券之星 · 2025-09-21
每周股票复盘：辰欣药业（603367）股东大会审议通过取消监事会
每周股票复盘：辰欣药业（603367）拟取消监事会并补流873万
证券之星 · 2025-09-14
每周股票复盘：辰欣药业（603367）拟取消监事会并补流873万
9月12日辰欣药业涨5.14%，多策略LOF基金重仓该股
证券之星 · 2025-09-12
9月12日辰欣药业涨5.14%，多策略LOF基金重仓该股
9月8日辰欣药业跌8.61%，多策略LOF基金重仓该股
证券之星 · 2025-09-08
9月8日辰欣药业跌8.61%，多策略LOF基金重仓该股
每周股票复盘：辰欣药业（603367）股东减持1%股份
证券之星 · 2025-09-07
每周股票复盘：辰欣药业（603367）股东减持1%股份
暂无数据
公司概况
公司名称：
辰欣药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-09-29
主营业务：
辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是大输液-玻瓶、大输液-非PVC软包、大输液-塑瓶、小容量注射剂、口服固体制剂、冻干粉针剂等。
发行价格：
11.66
{"stockData":{"symbol":"603367","market":"SH","secType":"STK","nameCN":"辰欣药业","latestPrice":17.18,"timestamp":1773199789000,"preClose":17.21,"halted":0,"volume":2664343,"delay":0,"changeRate":-0.0017,"floatShares":453000000,"shares":453000000,"eps":1.0885,"marketStatus":"午间休市","change":-0.03,"latestTime":"03-11 11:29:49","open":17.24,"high":17.4,"low":17.16,"amount":45935200,"amplitude":0.0139,"askPrice":17.18,"askSize":24,"bidPrice":17.17,"bidSize":439,"shortable":0,"etf":0,"ttmEps":1.0885,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773205200000},"marketStatusCode":3,"adr":0,"adjPreClose":17.21,"symbolType":"stock","openAndCloseTimeList":[[1773192600000,1773199800000],[1773205200000,1773212400000]],"highLimit":18.93,"lowLimit":15.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":452754129,"isCdr":false,"pbRate":1.27,"roa":"--","peRate":15.783188,"roe":"6.22%","epsLYR":1.12,"committee":0.625,"marketValue":7778000000,"turnoverRate":0.0059,"status":1,"floatMarketCap":7778000000},"requestUrl":"/m/hq/s/603367/tweets","defaultTab":"tweets","newsList":[{"id":"2601360735","title":"辰欣药业（603367）披露关于股东股份解除质押的公告，1月8日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360735","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360735?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:20","pubTimestamp":1767882028,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，辰欣药业报收于18.43元，较前一交易日上涨0.88%，最新总市值为83.44亿元。该股当日开盘18.29元，最高18.6元，最低18.26元，成交额达2.03亿元，换手率为2.44%。公司近日发布公告称，股东韩延振持有辰欣药业股份21,269,329股，占公司总股本的4.698%。本次解除质押股份11,340,000股，占其所持股份的53.32%，占公司总股本的2.50%。本次解除质押后，韩延振剩余被质押股份为0股。公司于2026年1月8日收到相关通知，解除质押手续已办理完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800038934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2601160005","title":"1月5日辰欣药业涨5.14%，富国新活力灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601160005","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601160005?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:33","pubTimestamp":1767598417,"startTime":"0","endTime":"0","summary":"重仓辰欣药业的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国新活力灵活配置混合A。吴栋栋在任的基金产品包括:富国质量成长6个月持有混合A，管理时间为2022年2月28日至今，期间收益率为50.66%；富国核心优势混合发起式A，管理时间为2023年12月1日至今，期间收益率为84.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2585468278","title":"11月24日辰欣药业现5笔大宗交易 机构净买入2997.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468278?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:59","pubTimestamp":1763978396,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日辰欣药业发生大宗交易，交易数据如下：近三个月该股共发生5笔大宗交易，合计成交2.43万手，折价成交5笔。该股近期无解禁股上市。截至2025年11月24日收盘，辰欣药业(603367)报收于18.36元，上涨0.33%，换手率2.94%，成交量13.33万手，成交额2.44亿元。该股近半年内有股东持股变动，合计净减持2158.52万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2585084271","title":"每周股票复盘：辰欣药业（603367）股东一致行动人更名不涉股权变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2585084271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585084271?lang=zh_cn&edition=full","pubTime":"2025-11-23 01:39","pubTimestamp":1763833148,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，辰欣药业报收于18.3元，较上周的21.62元下跌15.36%。本周关注点公司公告汇总：股东一致行动人变更名称、注册地址及经营范围，不涉及持股数量及比例变动。公司公告汇总辰欣药业股份有限公司接到持股5%以上股东韩延振的一致行动人通知，原名为南京辰昕同泰创业投资有限公司的企业已更名为江苏辰昕同泰企业管理有限公司，并完成注册地址和经营范围变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2584020183","title":"11月20日辰欣药业创60日新低，富国新活力灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584020183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584020183?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:32","pubTimestamp":1763623978,"startTime":"0","endTime":"0","summary":"重仓辰欣药业的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国新活力灵活配置混合A。吴栋栋在任的基金产品包括:富国质量成长6个月持有混合A，管理时间为2022年2月28日至今，期间收益率为38.87%；富国核心优势混合发起式A，管理时间为2023年12月1日至今，期间收益率为69.92%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000017682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2584621583","title":"辰欣药业（603367）披露持股5%以上股东一致行动人更名及经营范围变更，11月17日股价下跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584621583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584621583?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:13","pubTimestamp":1763388788,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，辰欣药业报收于21.29元，较前一交易日下跌1.53%，最新总市值为96.39亿元。该股当日开盘21.88元，最高21.98元，最低21.2元，成交额达7.39亿元，换手率为7.59%。公司近日发布公告称，接到持股5%以上股东韩延振的一致行动人通知，原名为南京辰昕同泰创业投资有限公司的企业已更名为江苏辰昕同泰企业管理有限公司，并完成注册地址和经营范围变更。本次变更不涉及持有公司股份数量及比例变动，对公司治理及经营活动无影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700036590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2580478731","title":"每周股票复盘：辰欣药业（603367）股东户数下降14.38%，三季度净利增19.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580478731","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580478731?lang=zh_cn&edition=full","pubTime":"2025-11-02 01:49","pubTimestamp":1762019350,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，辰欣药业报收于21.21元，较上周的23.23元下跌8.7%。本周，辰欣药业10月27日盘中最高价报23.26元。辰欣药业当前最新总市值96.03亿元，在化学制药板块市值排名58/151，在两市A股市值排名1953/5163。股本股东变化截至2025年9月30日，辰欣药业股东户数为3.08万户，较6月30日减少5165户，减幅14.38%。业绩披露要点辰欣药业2025年三季报显示，主营收入25.84亿元，同比下降13.94%；归母净利润3.82亿元，同比下降4.05%；扣非净利润2.74亿元，同比下降24.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2579112066","title":"股市必读：辰欣药业（603367）10月30日收盘跌5.6%，主力净流出1.25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579112066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579112066?lang=zh_cn&edition=full","pubTime":"2025-10-31 00:50","pubTimestamp":1761843024,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，辰欣药业报收于19.72元，下跌5.6%，换手率6.01%，成交量27.21万手，成交额5.45亿元。当日关注点来自“交易信息汇总”：辰欣药业10月30日收盘报19.72元，下跌5.6%，当日主力资金净流出1.25亿元，占总成交额22.86%。该股近5个交易日中有2日跌幅超5%。前10个交易日主力资金累计净流出2.48亿元，股价累计下跌6.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100002157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2578938657","title":"辰欣药业(603367.SH)发布前三季度业绩，归母净利润3.82亿元，同比下降4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578938657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578938657?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:32","pubTimestamp":1761640323,"startTime":"0","endTime":"0","summary":"智通财经APP讯，辰欣药业(603367.SH)披露2025年第三季度报告，公司前三季度实现营收25.84亿元，同比下降13.94%;归母净利润3.82亿元，同比下降4.05%;扣非净利润2.74亿元，同比下降24.60%;基本每股收益0.84元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603367"],"gpt_icon":0},{"id":"2577338011","title":"异动快报：辰欣药业（603367）10月22日10点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2577338011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577338011?lang=zh_cn&edition=full","pubTime":"2025-10-22 10:50","pubTimestamp":1761101424,"startTime":"0","endTime":"0","summary":"证券之星10月22日盘中消息，10点46分辰欣药业触及涨停板。目前价格24.2，上涨10.0%。其所属行业化学制药目前上涨。领涨股为广济药业。该股为肝素，医药，新冠病毒防治概念热股，当日肝素概念上涨1.5%，医药概念上涨0.67%，新冠病毒防治概念上涨0.5%。10月21日的资金流向数据方面，主力资金净流出9928.49万元，占总成交额8.73%，游资资金净流入1126.76万元，占总成交额0.99%，散户资金净流入8801.72万元，占总成交额7.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200013187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2576043568","title":"每周股票复盘：辰欣药业（603367）因股价涨幅偏离上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2576043568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576043568?lang=zh_cn&edition=full","pubTime":"2025-10-19 01:12","pubTimestamp":1760807529,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，辰欣药业报收于23.27元，较上周的20.23元上涨15.03%。本周，辰欣药业10月17日盘中最高价报23.27元。10月13日盘中最低价报19.27元。本周共计1次涨停收盘，无跌停收盘情况。辰欣药业当前最新总市值105.36亿元，在化学制药板块市值排名52/150，在两市A股市值排名1741/5158。本周关注点交易信息汇总：辰欣药业因日收盘价格涨幅偏离值达7%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2576802750","title":"10月17日辰欣药业（603367）龙虎榜数据：游资上海超短帮上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2576802750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576802750?lang=zh_cn&edition=full","pubTime":"2025-10-17 17:15","pubTimestamp":1760692519,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月17日公布的交易公开信息显示，辰欣药业因有价格涨跌幅限制的日收盘价格涨幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年10月17日收盘，辰欣药业报收于23.27元，上涨10.02%，涨停，换手率12.17%，成交量55.12万手，成交额12.48亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净买入5344.43万元。上海超短帮等知名游资榜上有名。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700027159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2570989608","title":"每周股票复盘：辰欣药业（603367）股东减持452万股，拟派现8511万","url":"https://stock-news.laohu8.com/highlight/detail?id=2570989608","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570989608?lang=zh_cn&edition=full","pubTime":"2025-09-28 01:50","pubTimestamp":1758995421,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，辰欣药业报收于19.84元，较上周的20.89元下跌5.03%。本周，辰欣药业9月22日盘中最高价报21.81元。公司公告汇总：辰欣药业拟每股派发现金红利0.18800元（含税），共计派发85,117,776.25元。股本股东变化股东增减持9月24日辰欣药业发布公告，股东石家庄四药有限公司于2025年9月23日合计减持352.0万股，占公司目前总股本的0.7775%，变动期间该股股价下跌4.33%，截止9月23日收盘报20.11元。公司公告汇总辰欣药业股份有限公司2025年半年度权益分派实施公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2570355081","title":"股市必读：9月24日辰欣药业发布公告，股东减持352万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2570355081","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570355081?lang=zh_cn&edition=full","pubTime":"2025-09-25 01:18","pubTimestamp":1758734297,"startTime":"0","endTime":"0","summary":"来自股本股东变化：石家庄四药有限公司于9月23日减持辰欣药业352.0万股，占总股本0.7775%。股本股东变化股东增减持9月24日辰欣药业发布公告《辰欣药业:辰欣药业股份有限公司关于持股5%以上股东减持股份计划完成暨减持股份结果公告》，其股东石家庄四药有限公司于2025年9月23日合计减持352.0万股，占公司目前总股本的0.7775%，变动期间该股股价下跌4.33%，截止9月23日收盘报20.11元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2569996117","title":"9月23日辰欣药业发布公告，股东减持100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2569996117","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569996117?lang=zh_cn&edition=full","pubTime":"2025-09-23 18:01","pubTimestamp":1758621679,"startTime":"0","endTime":"0","summary":"证券之星消息，9月23日辰欣药业发布公告《辰欣药业:辰欣药业股份有限公司关于持股5%以上的股东权益变动触及1%刻度的提示性公告》，其股东石家庄四药有限公司于2025年9月22日合计减持100.0万股，占公司目前总股本的0.2209%，变动期间该股股价上涨0.62%，截止9月22日收盘报21.02元。股东增减持详情见下表：根据辰欣药业2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300030124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2569112243","title":"每周股票复盘：辰欣药业（603367）股东大会审议通过取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569112243","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569112243?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:05","pubTimestamp":1758391515,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，辰欣药业报收于20.89元，较上周的22.48元下跌7.07%。本周，辰欣药业9月15日盘中最高价报22.75元。本周关注点公司公告汇总：辰欣药业股东大会审议通过不再设立监事会及监事的议案。公司公告汇总山东国曜琴岛（济南）律师事务所关于辰欣药业股份有限公司2025年第二次临时股东大会的法律意见书辰欣药业于2025年9月16日召开2025年第二次临时股东大会，会议由董事长杜振新主持，采取现场与网络投票结合方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0},{"id":"2567513812","title":"每周股票复盘：辰欣药业（603367）拟取消监事会并补流873万","url":"https://stock-news.laohu8.com/highlight/detail?id=2567513812","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567513812?lang=zh_cn&edition=full","pubTime":"2025-09-14 01:23","pubTimestamp":1757784187,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，辰欣药业报收于22.48元，较上周的25.21元下跌10.83%。本周关注点公司公告汇总：辰欣药业拟取消监事会，由董事会审计委员会行使监事会职权公司公告汇总：辰欣药业拟将cGMP固体制剂车间二期项目剩余尾款872.96万元永久补充流动资金公司公告汇总：辰欣药业拟召开2025年第二次临时股东大会审议多项治理制度修订议案公司公告汇总辰欣药业股份有限公司拟召开2025年第二次临时股东大会，审议多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603367"],"gpt_icon":0},{"id":"2566492126","title":"9月12日辰欣药业涨5.14%，多策略LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2566492126","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566492126?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:17","pubTimestamp":1757665066,"startTime":"0","endTime":"0","summary":"证券之星消息，9月12日辰欣药业涨5.14%，收盘报22.48元，换手率7.7%，成交量34.86万手，成交额7.7亿元。重仓辰欣药业的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为大成基金的多策略LOF。多策略LOF目前规模为0.9亿元，最新净值1.4458，较上一交易日上涨0.73%，近一年上涨24.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200024835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","160921","603367"],"gpt_icon":0},{"id":"2565501375","title":"9月8日辰欣药业跌8.61%，多策略LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565501375","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565501375?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:22","pubTimestamp":1757319729,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日辰欣药业跌8.61%，收盘报23.04元，换手率7.03%，成交量31.83万手，成交额7.58亿元。重仓辰欣药业的公募基金请见下表：根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为大成基金的多策略LOF。多策略LOF目前规模为0.9亿元，最新净值1.4218，较上一交易日上涨1.25%，近一年上涨20.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160921","603367","BK0239"],"gpt_icon":0},{"id":"2565651778","title":"每周股票复盘：辰欣药业（603367）股东减持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2565651778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565651778?lang=zh_cn&edition=full","pubTime":"2025-09-07 01:40","pubTimestamp":1757180415,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，辰欣药业报收于25.21元，较上周的25.46元下跌0.98%。本周，辰欣药业9月4日盘中最高价报28.23元。本周关注点交易信息汇总：辰欣药业因股价涨幅偏离值达7%登上龙虎榜。股本股东变化：韩延振减持公司股份4,509,200股，持股比例由7.06%降至6.07%。股本股东变化韩延振及其一致行动人南京辰昕同泰创业投资有限公司合计持股比例由7.36%降至6.37%。2024年度营业收入为39.82亿元，同比下降10.77%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603367","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773203989194,"stockEarnings":[{"period":"1week","weight":0.038},{"period":"1month","weight":-0.0138},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1875},{"period":"1year","weight":0.3107},{"period":"ytd","weight":-0.0064}],"compareEarnings":[{"period":"1week","weight":0.0001},{"period":"1month","weight":0.0142},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.064},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辰欣药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30760人(较上一季度减少14.38%)","perCapita":"14718股","listingDate":"2017-09-29","address":"山东省济宁市任城区高新区同济科技工业园","registeredCapital":"45275万元","survey":" 辰欣药业股份有限公司的主营业务是药品的研发、生产与销售。公司的主要产品是大输液-玻瓶、大输液-非PVC软包、大输液-塑瓶、小容量注射剂、口服固体制剂、冻干粉针剂等。","listedPrice":11.66},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辰欣药业,603367,辰欣药业股票,辰欣药业股票老虎,辰欣药业股票老虎国际,辰欣药业行情,辰欣药业股票行情,辰欣药业股价,辰欣药业股市,辰欣药业股票价格,辰欣药业股票交易,辰欣药业股票购买,辰欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辰欣药业(603367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辰欣药业(603367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}